CIBC Bancorp USA
LLY icon

CIBC Bancorp USA’s Eli Lilly LLY Stock Holding History

CIBC Bancorp USA’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$946M Sell
817,274
-89,211
-10% -$105M 1.18% 13
2026
Q2 		$1.09B Buy
906,485
+1,825
+0.2% +$1.86M 1.32% 10
2026
Q1 		$832M Buy
+904,660
New +$917M 1.12% 12
2025
Q3 		$84M Buy
+110,064
New +$81.9M 0.46% 36

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

CIBC Bancorp USA's LLY Position: Q3 2026 in Review

CIBC Bancorp USA reduced its Eli Lilly (LLY) stake by 9.8% in Q3 2026, selling an estimated $105M and leaving 817,274 shares worth $946M. The position accounts for 1.18% of the portfolio, ranked #13.

CIBC Bancorp USA first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.09B in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • CIBC Bancorp USA held 817,274 shares of Eli Lilly worth $946M as of Q3 2026.
  • CIBC Bancorp USA sold 89,211 Eli Lilly shares in Q3 2026, an estimated $105M.
  • Eli Lilly made up 1.18% of CIBC Bancorp USA's portfolio in Q3 2026, its #13 holding.
  • CIBC Bancorp USA first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • CIBC Bancorp USA's Eli Lilly position peaked at $1.09B in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.